RxDoctor Payments Data

Hayden Hoffler, DPM

Podiatrist · Catonsville, MDNPI 1306308135

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Stryker at 43.0% of the total. Reporting peaked in 2023 at $6,765 and has fallen 85.4% since, to $988 in 2025. Among podiatrist clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,815in general payments, 2019–2025

Across 171 payments — averaging $86.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Orthofix Medical, Inc.$3K
  • Southtech Orthopedics$1K
  • Arthrex$912
  • Treace Medical Concepts, Inc.$524
  • Fusion Orthopedics USA, LLC$489
  • plus $2K from 18 others

What the payments were for

  • Travel & lodging$7,43150%
  • Food & beverage$6,04441%
  • Education$1,3419%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,815 in reported general payments places this provider in the 95th percentile of 183 podiatrist providers in Maryland.

See all podiatrist providers in Maryland

Medicare billing

Part B allowed, 2024
$171,170
Medicare patients
535
Services billed
2,401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox28$1,357
Cephalexin11$254
Ondansetron OdtOndansetron17$107
Oxycodone Hcl23$77
Methylprednisolone16$70
Meloxicam41$65

Paid to pharmacies, not to this prescriber.

Other podiatrist in Catonsville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →